<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/38D3D2F5-1B35-4CA4-AA50-69967F931069"><gtr:id>38D3D2F5-1B35-4CA4-AA50-69967F931069</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Lord</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BB626A5D-FFCD-41F0-B2DB-A034CADB4CC4"><gtr:id>BB626A5D-FFCD-41F0-B2DB-A034CADB4CC4</gtr:id><gtr:firstName>Alfonso</gtr:firstName><gtr:surname>Martin-Fontecha</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7BC273D6-7DF3-4DFE-B835-E4C407817CE6"><gtr:id>7BC273D6-7DF3-4DFE-B835-E4C407817CE6</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>MacDonald</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802068"><gtr:id>219C27DD-1C08-4627-B0D5-7E8A0EEF903B</gtr:id><gtr:title>Defining the cellular and molecular pathogenesis of ulcerative colitis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802068</gtr:grantReference><gtr:abstractText>Ulcerative colitis (UC) is an incurable disease of the guts which can affect men, women and children of all ages. It can cause severe abdominal pain, bloody diarrhoea, and even cancer and many patients require surgery to help with these symptoms and complications. What is particularly worrying is that this condition is becoming more common and nobody really knows what causes it or what the best treatment is.

This research aims to understand more about what causes UC and may lead to the development of new therapies.
Our recent work has given us great insight in to what is likely to be going on in UC. We have found that one particular gene in cells of the immune system can upset the balance between ?good? and ?bad? bacteria in the gut and trigger inflammation in the bowel. 
The research showed that this gene (known as T-bet) controls the production of a key protein called TNF-alpha. Without T-bet, too much of this protein gets produced, which starts the process of inflammation in the gut. This in turn allows bacteria to cross from the gut into the body, which can aggravate the inflammation and cause ulcerative colitis. Our work is uncovering the ways in which the crucial balance between ?good? and ?bad? bacteria is maintained in the gut and what goes wrong when it is upset.
UC is one type of ?autoimmune disease? that occurs when the body?s immune system makes a mistake and attacks itself. This can be triggered by the breakdown of the barrier of cells that prevents immune cells from attacking bacteria in the bowel. We?ve found that the T-bet gene is essential for maintaining the integrity of that barrier ? it?s like a peacekeeper in our guts and without it, things can get nasty.
Knowing more about the events that lead to ulcerative colitis opens up several possible new ways to treat it. As well as developing drugs that affect T-bet, another approach might be to use special ?regulatory immune cells?, which have already proved effective at treating ulcerative colitis in mice.
These results are very important and we hope to study these mice in a more detailed way to discover new treatments for patients with this disease, such as giving back some regulatory T cells.
We aim to take these findings from the lab and turn them into new treatments to help patients as quickly as possible.</gtr:abstractText><gtr:technicalSummary>Ulcerative Colitis (UC) is an inflammatory bowel disease of unknown aetiology and rapidly rising incidence that causes significant morbidity and mortality and represents a significant unmet healthcare need.
 We have recently developed a novel model of UC (TRUC=T-bet, RAG, Ulcerative Colitis) that begins to explain many aspects of this disease at a cellular and molecular level (Cell 2007; 131, 33-45). This model has been highlighted as revealing fundamental insight into disease pathogenesis (Cell 2007; 131, 15-17) and having particular relevance for translation (NEJM 2008; 358, 528-530). The absence of the transcription factor T-bet in the innate immune system causes a spontaneous, transmissible and fully penetrant colitis that is a phenocopy of human UC. The severity of this disease can be modulated by adoptive transfer of regulatory T cells (Tregs), antibody blockade of TNF-alpha and is also critically dependent on the gut microflora. 
 Based on a substantial body of new data, we will define our model in further detail and provide the translational platform for novel therapeutic modalities for human UC. 

We will:

1. Determine the cellular and molecular mechanisms of disease pathogenesis.
i. As natural killer (NK) cells are hyperactivated in the TRUC mouse, these cells are probably important determinants of colitis. We will address this by antibody-mediated and genetic deletion of T-bet and NK cells in TRUC mice.
ii. At the molecular level, the defect appears to map to transcriptional repression at the TNF-alpha promoter by T-bet in colonic dendritic cells (DCs). We will test if DCs are critical for the pathogenesis of colitis by selective depletion of DCs utilizing the CD11c-DTR/GFP and T-betfl/fl x CD11c-Cre mouse.
iii. We have found that colonic epithelial apoptosis is the earliest histological event observed in the TRUC mouse. By crossing the TRUC model with the Lgr5 reporter mouse, we will be able to follow stem cell kinetics as colitis evolves to determine the role of the colonic epithelial stem cell in UC pathogenesis.

2. Elucidate the pathways that control colitis at a cellular, therapeutic biological and microbiological level.
i. We will investigate whether adoptively transferred Tregs directly control DC cytokine production.
ii. We will ascertain the most effective biological therapy for colitis.
iii. We will determine the cytokines involved in transmitted colitis and the response to biological therapy.

By validating these findings in parallel with human studies, we will translate our findings into real change in the management of human UC.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1172597</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Colitis models</gtr:description><gtr:id>DC4E2BFC-7BF5-4149-81C9-680819F8588F</gtr:id><gtr:impact>Book chapter in major mucosal immunology textbook.
Further leverage funding from NIHR and Wellcome
Joint publications</gtr:impact><gtr:outcomeId>dA5UVPtJgLF-1</gtr:outcomeId><gtr:partnerContribution>Intellectual Input, shared research fellows</gtr:partnerContribution><gtr:piContribution>A number of novel pre-clinical colitis models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>460471</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR clinical training fellowship and clinical trial grant</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>51EF0682-504F-4D28-880D-F520E82F131F</gtr:id><gtr:outcomeId>X8sKbjVkYAu0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>457611</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Training Fellowship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D8421979-908D-498D-952D-914380E6C4E9</gtr:id><gtr:outcomeId>dBRgnNPw16b0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>239637</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical training fellowship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>D3879026-2606-44B1-B901-6AD2D526262E</gtr:id><gtr:outcomeId>LRw7nYVSqHr0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSTT Charity Programme grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>5C85C3AB-ABA4-4DED-A516-578F068D710F</gtr:id><gtr:outcomeId>LoGU6H725ZA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>780000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR BRC immune monitoring programme</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0F664D3A-BEC8-406F-BD0A-0F10890AFE02</gtr:id><gtr:outcomeId>Rvw5PDhSqQ90</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Novel lines of genetically modified mice</gtr:description><gtr:id>7A0BF861-419D-4E4C-AD8A-73B93E1F28F0</gtr:id><gtr:impact>One specific model chosen for a major editorial piece in the New England Journal of Medicine as ready for translation in the &amp;quot;Clinical implications of basic research&amp;quot; section of the journal</gtr:impact><gtr:outcomeId>jRsYp7kz1TS</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>colitis model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>015BF662-8452-4C87-8434-26CC013125AD</gtr:id><gtr:title>Integration of lyoplate based flow cytometry and computational analysis for standardized immunological biomarker discovery.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d338561644fdd89f5550f2a924a17e4"><gtr:id>8d338561644fdd89f5550f2a924a17e4</gtr:id><gtr:otherNames>Villanova F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14757_27_23843942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B5F7BA1-CD24-4488-A700-5D23D55E61DA</gtr:id><gtr:title>Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>ehEAuhPZeW5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8627A26-EED0-4F98-901B-CD4742F50414</gtr:id><gtr:title>Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/106c16d6f9893f7a7d87dd13518ba4f7"><gtr:id>106c16d6f9893f7a7d87dd13518ba4f7</gtr:id><gtr:otherNames>Canavan JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56dd80139f8583.23629465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5471AD6D-4639-4C46-9F30-99E5CD5DFEB3</gtr:id><gtr:title>Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1554229d6b4eef4c2f1c49aa05b787cd"><gtr:id>1554229d6b4eef4c2f1c49aa05b787cd</gtr:id><gtr:otherNames>de Jong E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>KzpN5E6joTF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B27B3FF1-4FD2-41E3-8FD0-BA2261AFBC07</gtr:id><gtr:title>Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1? production by dendritic cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f8caf6bb1e8b53c636a561310a37dca"><gtr:id>3f8caf6bb1e8b53c636a561310a37dca</gtr:id><gtr:otherNames>Mitchell PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>SnUwCCnDdTh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D59EDF87-D26F-4146-9463-4341C2C1529A</gtr:id><gtr:title>Transcriptional control of natural killer cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59d2730ea04b11401c1f18023e0ec64f"><gtr:id>59d2730ea04b11401c1f18023e0ec64f</gtr:id><gtr:otherNames>Mart?n-Fontecha A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>BSPMfmX8vgh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57F95C49-AC82-4C10-8B53-6E0A38330317</gtr:id><gtr:title>Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edc83dd42076f46d7127c1b6b920e2a2"><gtr:id>edc83dd42076f46d7127c1b6b920e2a2</gtr:id><gtr:otherNames>Cardone J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>s2neTq7sCzv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C998B7D0-3BB2-4DD3-9B9C-4D89C44CE723</gtr:id><gtr:title>A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/106c16d6f9893f7a7d87dd13518ba4f7"><gtr:id>106c16d6f9893f7a7d87dd13518ba4f7</gtr:id><gtr:otherNames>Canavan JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14757_27_22219224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A20FF45-2706-4B50-99AB-0D6279E76E33</gtr:id><gtr:title>Role and species-specific expression of colon T cell homing receptor GPR15 in colitis.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5bbe676001f17b5a6cd78e73fc8138"><gtr:id>1d5bbe676001f17b5a6cd78e73fc8138</gtr:id><gtr:otherNames>Nguyen LP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>doi_55f984984f303946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>925ED533-A027-471D-83EE-CF0CDC379D69</gtr:id><gtr:title>A central role for monocytes in Toll-like receptor-mediated activation of the vasculature.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af9cf1603ba8689b71fea78eea52b3db"><gtr:id>af9cf1603ba8689b71fea78eea52b3db</gtr:id><gtr:otherNames>Ward JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_14757_17_19689736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB576C27-C86F-4A0F-82ED-31533FE8DB90</gtr:id><gtr:title>Response to microbiota associated with disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77f38e8936966784c05cbb48b400333e"><gtr:id>77f38e8936966784c05cbb48b400333e</gtr:id><gtr:otherNames>Powell Nicholas</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>Zb57RvUMGCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CB0C4F2-81EC-4BAC-83D1-C48217D9A083</gtr:id><gtr:title>T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pfj2qpJZoiN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6F834A-0A3B-47FD-9665-D651D20FCEE0</gtr:id><gtr:title>T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2a70b861c9ef430a92720e545afc638"><gtr:id>e2a70b861c9ef430a92720e545afc638</gtr:id><gtr:otherNames>Hertweck A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d67d2ad9fa6.77343770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99168222-3758-4D10-BE6E-147893723039</gtr:id><gtr:title>An imaging flow cytometric method for measuring cell division history and molecular symmetry during mitosis.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a26036af1a4074b9cb123e9a5013559f"><gtr:id>a26036af1a4074b9cb123e9a5013559f</gtr:id><gtr:otherNames>Filby A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>FbgNbj3aib6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3C2E63E-2BC5-4BF6-9366-FF23F6F06E80</gtr:id><gtr:title>The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e953f2388818be25588d7a4cd333da5a"><gtr:id>e953f2388818be25588d7a4cd333da5a</gtr:id><gtr:otherNames>Jenner RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>dtCDtgrKmm4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A457A301-DC26-4B81-BBD7-16A204F75F2D</gtr:id><gtr:title>Transcriptional regulation of the mucosal immune system mediated by T-bet.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c527f88ccb091966ae1ccaa57f48d497"><gtr:id>c527f88ccb091966ae1ccaa57f48d497</gtr:id><gtr:otherNames>Powell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>EDCVSzUvBhy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5474E5D4-7EF4-4157-9BA4-3C73B34EBD36</gtr:id><gtr:title>T-bet: a bridge between innate and adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9080e0d6fa9107a456ae38ee165626f9"><gtr:id>9080e0d6fa9107a456ae38ee165626f9</gtr:id><gtr:otherNames>Lazarevic V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_14757_27_24113868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3073319-C52B-4691-BB83-DBBEA07EF756</gtr:id><gtr:title>T-bet, a Th1 transcription factor regulates the expression of Tim-3.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db48bdd4882b5d23b37b18ced6cce20d"><gtr:id>db48bdd4882b5d23b37b18ced6cce20d</gtr:id><gtr:otherNames>Anderson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>tuFu8cKAbBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E046183C-8E93-4C3D-9806-1104DC04B3C6</gtr:id><gtr:title>Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b001ee642263a897d55eb3c68d53eb"><gtr:id>72b001ee642263a897d55eb3c68d53eb</gtr:id><gtr:otherNames>Evans HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>sJbHtTEF42H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BF05103-E722-4BB5-A0E6-5562A968886A</gtr:id><gtr:title>Relative roles of Th1 and Th17 effector cells in allograft rejection.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5612980a3fff3de4ff661b27748cd3f5"><gtr:id>5612980a3fff3de4ff661b27748cd3f5</gtr:id><gtr:otherNames>Atalar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>pm_14757_17_19337142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>947FDEBD-CECE-4B1E-857F-AD41FB6FDA97</gtr:id><gtr:title>Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn><gtr:outcomeId>pm_14757_27_23580782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A3B24AC-8D10-40E4-9D39-78E6C040CD59</gtr:id><gtr:title>Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14757_27_22961000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D5C0ADF-5833-4CC2-B87A-B188148229FA</gtr:id><gtr:title>The challenges of stratifying patients for trials in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd3c7bb2e0c18b309a753ad12f80deb4"><gtr:id>fd3c7bb2e0c18b309a753ad12f80deb4</gtr:id><gtr:otherNames>Biancheri P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_14757_27_24035478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D275174-923A-41EA-BEAD-64A4058CC700</gtr:id><gtr:title>Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e476949dc4c4ee8bd7d9c756e635262"><gtr:id>1e476949dc4c4ee8bd7d9c756e635262</gtr:id><gtr:otherNames>Stolarczyk E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>pm_14757_27_23562076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FCC9089-E9F5-4D68-900B-4C7E726B088F</gtr:id><gtr:title>Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41e21049ed36ea2a66f7459fa8c75155"><gtr:id>41e21049ed36ea2a66f7459fa8c75155</gtr:id><gtr:otherNames>Mells GF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14757_27_21399635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD6B8ECC-F2BD-49E0-BFFB-F182ACE0F186</gtr:id><gtr:title>Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d136cb0b10a6c9ffc7a02a0d6f2ffb"><gtr:id>27d136cb0b10a6c9ffc7a02a0d6f2ffb</gtr:id><gtr:otherNames>Hernandez-Fuentes MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>5a995ecc502ce7.11487218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D81862-BFED-4B58-B5A8-7AA56C4AC35F</gtr:id><gtr:title>In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b001ee642263a897d55eb3c68d53eb"><gtr:id>72b001ee642263a897d55eb3c68d53eb</gtr:id><gtr:otherNames>Evans HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14757_17_19325128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67A83EEC-DE3A-4FCE-8672-D20E8E794E53</gtr:id><gtr:title>CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683d85c4205a3be0e17b5d658643e8a1"><gtr:id>683d85c4205a3be0e17b5d658643e8a1</gtr:id><gtr:otherNames>Elgueta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_55f984984f39083e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B58CE62-A766-4B3C-9FFB-878D37A227D3</gtr:id><gtr:title>The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c527f88ccb091966ae1ccaa57f48d497"><gtr:id>c527f88ccb091966ae1ccaa57f48d497</gtr:id><gtr:otherNames>Powell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_14757_27_23063332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B868672-BFCA-441A-89B9-21F6090274D4</gtr:id><gtr:title>Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5162e615d94473b9c6a4c9a6efbc8d7"><gtr:id>e5162e615d94473b9c6a4c9a6efbc8d7</gtr:id><gtr:otherNames>Garrett WS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>DU1GsHNraJp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C89DE9AE-3477-482B-B13A-29EEF3C0CFA9</gtr:id><gtr:title>Monocytes control natural killer cell differentiation to effector phenotypes.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ccf9faaa1f42b507e4b9de00b98315c"><gtr:id>0ccf9faaa1f42b507e4b9de00b98315c</gtr:id><gtr:otherNames>Soderquest K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>VCNyPBeeRS1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A72883B5-6145-49DD-B1B1-E778DB7F9A96</gtr:id><gtr:title>The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2bc2daade7204b0c32c705a148fed78"><gtr:id>e2bc2daade7204b0c32c705a148fed78</gtr:id><gtr:otherNames>Male V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>54637b02813c56.47739251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B084FEA6-27FC-48C2-880B-E94F5B120E16</gtr:id><gtr:title>Human immunodeficiency virus Tat associates with a specific set of cellular RNAs.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c33a927cf680d51490b4de1a6aaa092"><gtr:id>6c33a927cf680d51490b4de1a6aaa092</gtr:id><gtr:otherNames>Bouwman RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_540e165e165c7f856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD76159B-4BE3-49F0-803F-F8583D4B26A3</gtr:id><gtr:title>Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c527f88ccb091966ae1ccaa57f48d497"><gtr:id>c527f88ccb091966ae1ccaa57f48d497</gtr:id><gtr:otherNames>Powell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5675e3536648e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0595B1E-D89B-4A25-ABBA-0E08AB2BFE03</gtr:id><gtr:title>Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cd3f637b7203d98d16d16438c247dd"><gtr:id>78cd3f637b7203d98d16d16438c247dd</gtr:id><gtr:otherNames>Ramasubramanyan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5675e0f20b30a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC7051D7-CA8E-4F2E-8CD4-375AF408B154</gtr:id><gtr:title>RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ad75e0b12c404a6e6d1130d9912a1b3"><gtr:id>1ad75e0b12c404a6e6d1130d9912a1b3</gtr:id><gtr:otherNames>Gunnell A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>585d67d6040eb0.99003838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF6145CA-B2BB-4E42-B92B-16B218C07140</gtr:id><gtr:title>The immune cell transcription factor T-bet: A novel metabolic regulator.</gtr:title><gtr:parentPublicationTitle>Adipocyte</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e476949dc4c4ee8bd7d9c756e635262"><gtr:id>1e476949dc4c4ee8bd7d9c756e635262</gtr:id><gtr:otherNames>Stolarczyk E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2162-3945</gtr:issn><gtr:outcomeId>54637b94e901b9.38128230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A77935D-6249-416D-A1C6-247E9D86A1A5</gtr:id><gtr:title>Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ccf9faaa1f42b507e4b9de00b98315c"><gtr:id>0ccf9faaa1f42b507e4b9de00b98315c</gtr:id><gtr:otherNames>Soderquest K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>rcHPqebhc83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02E513BB-19E7-4307-97E1-09F7BBAB6FE3</gtr:id><gtr:title>Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy.</gtr:title><gtr:parentPublicationTitle>Expert review of molecular diagnostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/106c16d6f9893f7a7d87dd13518ba4f7"><gtr:id>106c16d6f9893f7a7d87dd13518ba4f7</gtr:id><gtr:otherNames>Canavan JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-7159</gtr:issn><gtr:outcomeId>pm_14757_27_23256698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F7DA301-9798-4DB2-8AF0-D7C0415E189E</gtr:id><gtr:title>Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b056ebd525a3f82e22b1c43010afc913"><gtr:id>b056ebd525a3f82e22b1c43010afc913</gtr:id><gtr:otherNames>G?kmen MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14757_27_24249732</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802068</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>